Document Detail


Cortical changes in incipient Alzheimer's disease.
MedLine Citation:
PMID:  20930288     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Mild cognitive impairment (MCI) is defined by memory impairment with no impact on daily activities. 10 to 15% of MCI convert to Alzheimer's disease (AD) per year. While structural changes in the cortex of AD patients have been extensively investigated, fewer studies analyzed changes in the years preceding conversion. 46 MCI patients and 20 healthy controls underwent structural 1.0T-weighted high-resolution MR scans at baseline and after 1.4 (SD 0.3) years. All subjects were assessed yearly for up to 4 years with a comprehensive neuropsychological battery. Sixteen of the 46 patients converted to AD (cMCI) while 30 remained stable (sMCI). An accurate voxel-based statistical mesh-model technique (cortical pattern matching) with a related region-of-interest analysis based on networks defined from a Brodmann area atlas (BAs) were used to map gray matter changes over time. At baseline, cMCI patients had 10 to 30% less cortical gray matter volume than healthy controls in regions known to be affected by AD pathology (entorhinal, temporoparietal, posterior cingulate, and orbitofrontal cortex, p=0.0001). Over time, cMCI patients lost more gray matter than sMCI in all brain areas but mainly in the olfactory and in the polysynaptic hippocampal network (more than 8% gray matter loss, p<0.024). sMCI patients had 10 to 20% less volume than controls in the posterior cingulate and orbitofrontal cortex (p<0.008) although their progression over time was significantly slower than cMCI. AD patients in the MCI stage show greater gray matter loss in the olfactory and polysynaptic hippocampal network. These findings are in line with neuropathological knowledge.
Authors:
Annapaola Prestia; Valeria Drago; Paul E Rasser; Matteo Bonetti; Paul M Thompson; Giovanni B Frisoni
Related Documents :
20205668 - Alzheimer's disease (ad) and mild cognitive impairment (mci) patients are characterized...
3190498 - Personality alterations in dementia of the alzheimer type.
9117548 - Somatostatin, its molecular forms and monoaminergic transmitter metabolites in binswang...
3167398 - Measuring the course of alzheimer's disease. a longitudinal study of neuropsychological...
16943958 - Preventing sudden death and the use of prophylactic implanted defibrillators.
1713218 - Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the r...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of Alzheimer's disease : JAD     Volume:  22     ISSN:  1875-8908     ISO Abbreviation:  J. Alzheimers Dis.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2011-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9814863     Medline TA:  J Alzheimers Dis     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1339-49     Citation Subset:  IM    
Affiliation:
Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, The National Centre for Research and Care of Alzheimer's and Mental Diseases, Brescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Grouping and Trajectories of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease. Part II...
Next Document:  Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, par...